Clinical Trial Update: Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study evaluating Zactima in combination with chemotherapy for metastatic pancreatic cancer has completed. The trial was sponsored by S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Zactima (vandetanib)

Snippet

Sponsor: Sanofi | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED